Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.
Frequently asked questions
What sector does NanoCarrier Co Ltd (4571) operate in?
NanoCarrier Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is NanoCarrier Co Ltd (4571) current stock price?
As of the latest data, NanoCarrier Co Ltd stock price is ¥99, with a previous close of ¥99.
What is NanoCarrier Co Ltd (4571) current market capitalization?
NanoCarrier Co Ltd market cap is approximately 8.27 billion.
What is NanoCarrier Co Ltd (4571) Earnings Per Share (EPS)?
The trailing EPS is -¥13.
What is NanoCarrier Co Ltd (4571) EBITDA?
NanoCarrier Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -275.88 million.
Does NanoCarrier Co Ltd (4571) pay dividends?
No. NanoCarrier Co Ltd does not pay a dividend.
What is NanoCarrier Co Ltd (4571) beta (volatility) score?
NanoCarrier Co Ltd has a beta of 0.385, indicating lower volatility than the overall market.
